Lexoraa Ind (531944)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 110.91% and profit growth of 114.29% show early traction from a small base.
• Reported ROE of 22.72% is high, though it must be verified against negative ROCE.
• Piotroski F-Score of 6/9 points to moderate overall financial health.
• The latest quarter has positive sales of ₹1 Cr, so the business is not dormant.
• The stock trades at ₹19.50, near the top of its ₹12-₹21 range, reflecting recent market interest.

Concerns

• Latest quarter net profit is ₹0 Cr and P/E is 0.00, so there is no current earnings anchor for valuation.
• ROCE of -130.30% suggests operating capital is being destroyed; the core industrial-products business may not be profitable.
• Critical data are missing: book value, debt/equity, promoter holding, and FairStock Score are N/A, making balance sheet and governance assessment impossible.
• Absolute scale is tiny—₹1 Cr quarterly sales and ₹8 Cr market cap—and no dividend is paid.

AI Analysis

At ₹19.50, Lexoraa Ind carries a market cap of only ₹8 crore. In my world, size is not a sin, but obscurity is a challenge when there is no book value, no debt/equity, no promoter holding, and no meaningful earnings. With a P/E of 0.00 and net profit of ₹0 Cr in the latest quarter, there is no earnings anchor. The 110.91% sales growth and 114.29% profit growth sound exciting, but absolute numbers expose the truth: last quarter sales were ₹1 crore and net profit was ₹0 crore. You cannot build a fortress on an empty lot. The negative ROCE of -130.30% is a red flag that operating capital is being destroyed, even while ROE shows 22.72%. That contradiction tells me the reported profit may not come from the core business or that the equity base is so thin that any profit distorts the ratio. Without audited detail, I cannot trust the quality of those earnings. The Piotroski score of 6/9 is mildly encouraging, but it is not a moat. There is no dividend, and the price sits near the ₹21 high in a ₹12 to ₹21 range, leaving little margin of safety. Graham would ask: what is the earning power? The answer, at least this quarter, is zero. This is a small, speculative industrial-products stock, not a compounder. I am not interested in owning a business whose economics I cannot verify. Let it prove itself with years of positive operating returns, real debt disclosure, and consistent profits. Until then, this is a pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer